ST. PAUL, Minn.--(BUSINESS WIRE)--Torax Medical is pleased to announce that LINX®, its revolutionary solution for GERD, will be highlighted in several presentations at the upcoming Annual Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting. The SAGES meeting is being held in Nashville, TN from April 14 – 18th.
A schedule of events is included below.
Wednesday, April 15th
Advances in Foregut Surgery: GERD in 2015: Who, What and When? Fundoplication is Out…..Place Some Magnets; Shanu Kothari, MD Gunderson Health System will present at 8:10 am in Delta Ballroom B.
Thursday, April 16th
Magnetic Sphincter Augmentation: Endoscopic and Laparoscopic Visualization of Function; Jessica L. Reynolds, MD, University of Southern California, will present the video during the Exhibit Hall Video Presentation Session from 2:00 – 4:00 PM in the Ryman Hall C – Theater.
Friday, April 17th
Multi Institutional Outcomes Using Magnetic Sphincter Augmentation Versus Nissen Fundoplication for Chronic Gastro-esophageal Reflux Disease; Jessica L. Reynolds, MD, University of Southern California, will present the findings during the Plenary 1 Session from 8:30 – 10:00 AM in Delta Ballroom A.
Charges, Complications, and Outcome: A Comparison of Laparoscopic Nissen Fundoplication Versus Magnetic Sphincter Augmentation for GERD; Jessica L. Reynolds, MD, University of Southern California, will present the findings during the Resident/Fellows Scientific Session from 3:30 – 5:30 PM in Bayou A/B.
Friday, April 17th
– Saturday, April 18th
Ryman Exhibit Hall C
9:30 AM – 4:00PM Daily
Manometric Changes to the Lower Esophageal Sphincter Following Magnetic Sphincter Augmentation in Patients with Gastro-Esophageal Reflux Disease; Heather F. Warren, MD, Swedish Cancer Institute and Medical Center; P196
Introduction of LINX® Reflux Management System in a Community Heartburn Center; F. Paul Buckley, III, MD FACS, Scott & White Healthcare; P198
A Dysphagia/Odynophagia Survey Tool for Magnetic Augmentation of the Lower Esophageal Sphincter for Gastro-esophageal Reflux Disease; Heidi Ryan, MD, University of Nevada School of Medicine; P190
Todd Berg, President and CEO for Torax Medical said, "It’s exciting to see surgeons independently reporting their clinical experience and success with the LINX procedure in everyday practice. The data being presented further validates the LINX is now an important treatment option for patients suffering from chronic GERD. Reflux is a sphincter disease and can have serious implications if not treated; patients need better options to address this problem.”
Torax Medical will be hosting an exhibit at the meeting where attendees can participate in product demonstrations and learn more about the growing body of clinical evidence supporting LINX’s safety and efficacy. To learn more about the LINX Reflux Management System during the SAGES meeting, please stop by our booth #446 or visit www.linxforlife.com.
The LINX Reflux Management System
LINX is a small implant comprised of interlinked titanium beads with magnetic cores. The magnetic attraction between the beads augments the existing esophageal sphincter’s barrier function to prevent reflux. The device is implanted using a standard minimally invasive laparoscopic procedure and is an alternative to the more anatomically disruptive fundoplication, commonly used in surgical anti-reflux procedures. The LINX Reflux Management System is indicated for those patients diagnosed with GERD as defined by abnormal pH testing, and who continue to have chronic GERD symptoms despite maximum medical therapy for the treatment of reflux.
LINX does require a surgical procedure and is associated with potential risks, contraindications and life style modifications. For more information on LINX, including a statement of risks, please visit www.linxforlife.com.
About Torax Medical
Torax Medical, Inc. is a privately-held medical device company headquartered in St. Paul, Minnesota that develops and markets products designed to treat sphincter disorders utilizing its technology platform, Magnetic Sphincter Augmentation (MSA). Torax Medical is currently marketing the LINX® Reflux Management System for the treatment of GERD in the U.S. and Europe and the FENIX™ Continence Restoration System for the treatment of Fecal Incontinence (FI) in Europe. For more information, please visit www.toraxmedical.com.